The Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008. An assessment by the Australian and New Zealand Intensive Care Society
Open Access
- 1 March 2008
- journal article
- editorial
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 36 (2), 149-151
- https://doi.org/10.1177/0310057x0803600202
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Hydrocortisone Therapy for Patients with Septic ShockThe New England Journal of Medicine, 2008
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisThe New England Journal of Medicine, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli LillyThe New England Journal of Medicine, 2006
- Intensive Insulin Therapy in the Medical ICUThe New England Journal of Medicine, 2006
- Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic ShockJAMA, 2002
- Intensive Insulin Therapy in Critically Ill PatientsThe New England Journal of Medicine, 2001
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockThe New England Journal of Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisThe New England Journal of Medicine, 2001